Bio-Rad Laboratories (BIO) | Stock Overview & Key Data

Bio-Rad Laboratories Inc. | Healthcare

$248.67

2.25%

| Compare Stocks:

Bio-Rad Laboratories vs Abbott Laboratories Bio-Rad Laboratories vs Boston Scientific Bio-Rad Laboratories vs Masimo Bio-Rad Laboratories vs Globus Medical Bio-Rad Laboratories vs Bio-Rad Bio-Rad Laboratories vs S&P 500 | Market

Bio-Rad Laboratories Performance Comparison

Loading chart data...

Bio-Rad Laboratories

Healthcare Sector

S&P 500

View Full Price History

Stock Range

Today's Range

Low: $238.70 High: $249.94

on May 16, 2025

52 Week Range

Low: $215.38 High: $387.99

on April 7, 2025

on November 6, 2024

All-Time High: $832.70 on August 30, 2021

Key Statistics

Market Cap i $6.6B

EPS i -76.53

P/E Ratio (TTM) i -3.70

Forward P/E i 20.87

P/B Ratio i 1.01

PEG Ratio i 20.87

Div. Yield i 0.00%

ROE i -27.52%

Beta i 1.002

Debt to Equity i 20.50

Financial Highlights

Profitability

Gross Margin i 52.27%

Operating Margin i 9.72%

Profit Margin i -85.16%

Returns and Earnings

Return on Assets (TTM) i 1.55%

Return on Equity (TTM) i -27.52%

EBITDA i $486.2M

Net Income (TTM) i $-2.2B

Growth

Revenue (TTM) i

Revenue Per Share (TTM) i

Quarterly Revenue Growth i

Quarterly Earnings Growth i

Peer Performance Comparison

Company	Market Cap	1W	1M	3M	6M	YTD	1Y	3Y	5Y
Bio-Rad Laboratories BIO	6.57B Mid-cap	4.19%	1.41%	-12.20%	-20.59%	-23.76%	-15.41%	-52.40%	-47.39%
Abbott Laboratories ABT	232.01B Mega-cap	1.16%	3.92%	3.53%	14.84%	18.81%	29.48%	19.02%	47.35%
Boston Scientific BSX	155.14B Large-cap	3.08%	11.32%	0.65%	17.22%	18.63%	42.04%	170.35%	195.27%
Masimo MASI	8.37B Mid-cap	-0.72%	2.49%	-13.81%	-3.35%	-7.78%	25.22%	10.03%	-37.00%
Globus Medical GMED	7.83B Mid-cap	9.73%	-13.90%	-27.80%	-25.15%	-25.15%	-4.86%	-5.62%	11.18%
Bio-Rad BIO.B	7.01B Mid-cap	6.68%	11.00%	-19.86%	-25.32%	-23.19%	-10.66%	-50.48%	-46.37%

Ownership & Short Interest

Insider Ownership i 15.58%

Institutional Ownership i 91.40%

Shares Short i 1M

Short Ratio i 2.81

Short % of Shares Outstanding i 5.52%

Average 10-Day Volume i 373K

Average 90-Day Volume i 384K

Bio-Rad Laboratories Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Bio-Rad Laboratories would have performed over time.

Investment Amount

Investment Frequency

Start Date

End Date (Optional)

If not specified, the latest available data will be used

Reinvest Dividends

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

What is BIO's 52-week high and low?

In the last 52 weeks, Bio-Rad Laboratories reached a high of $387.99 (on November 6, 2024) and a low of $215.38 (on April 7, 2025).

What is the market cap and P/E ratio for BIO?

Curious about Bio-Rad Laboratories's size and valuation? Its market capitalization stands at 6.57B. When it comes to valuation, the P/E ratio (trailing twelve months) is -3.70, and the forward P/E (looking ahead) is 20.87.

Does BIO pay dividends? If so, what's the yield?

As for dividends, Bio-Rad Laboratories isn't currently offering a significant yield, or that specific data isn't available right now. Its payout ratio, which shows how much of its earnings are paid as dividends, is 0.00%.

Who are Bio-Rad Laboratories's main competitors or similar companies to consider before investing?

When looking at Bio-Rad Laboratories, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
Abbott Laboratories ABT	232.01B	Healthcare	Medical Devices	29.48%	19.02%
Boston Scientific BSX	155.14B	Healthcare	Medical Devices	42.04%	170.35%
Masimo MASI	8.37B	Healthcare	Medical Devices	25.22%	10.03%
Globus Medical GMED	7.83B	Healthcare	Medical Devices	-4.86%	-5.62%
Bio-Rad BIO.B	7.01B	Healthcare	Medical Devices	-10.66%	-50.48%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for Bio-Rad Laboratories Inc.? (e.g., ROE, Debt/Equity)

To get a sense of Bio-Rad Laboratories's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -27.52%, the Debt to Equity ratio from the most recent quarter is 20.50, and its Gross Profit Margin stands at 52.27%.

What is the recent revenue and earnings growth for BIO?

Looking at Bio-Rad Laboratories's growth, its revenue over the trailing twelve months (TTM) was $3B. Compared to the same quarter last year (YoY), quarterly revenue grew by -4.20%, and quarterly earnings saw a YoY growth of -83.30%.

How much of BIO stock is held by insiders and institutions?

Wondering who owns Bio-Rad Laboratories stock? Company insiders (like executives and directors) hold about 15.58% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 91.40%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.